Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMPHETAMINE SULFATE

AMPHETAMINE SULFATE

Standard Dose
5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AMPHETAMINE SULFATE is listed in Drugs@FDA under application 083901 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPHETAMINE SULFATE Form and strength TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LANNETT Submission history Latest submission status date: 2023-10-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPHETAMINE SULFATE is listed in Drugs@FDA under application 083901 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPHETAMINE SULFATE Form and strength TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LANNETT Submission history Latest submission status date: 2023-10-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.